Skip to content

Funding Opportunity: Research on Women’s Health in U3 Populations

The DE CTR ACCEL Program is looking for investigators interested in responding to the following NIH NOSI:

Notice of Special Interest (NOSI): Research on the Health of Women of Underrepresented, Underserved, and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)

NOT-OD-24-179: Notice of Special Interest (NOSI): Research on the Health of Women of Underrepresented, Underserved, and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)

Please note:

  • Only one U3 Administrative Supplement award per period of performance is permitted to a peer-reviewed NIH-funded grant
    Therefore, please read the full details at the link above. If you are interested in applying through the ACCEL Program, please email a Letter of Interest to Karen Hough at khough@udel.edu, by Monday, December 2, 2024, 12 noon. This letter is a one-page document describing your Specific Aims and your research team. If more than one project is proposed, the ACCEL Executive Committee will determine which project will move forward to an NIH submission based upon the Letter of Interest.
Here are some highlights of the NOSI

First Available Due Date: January 22, 2025

Budget
  • The application budget should not exceed $140,000 in direct costs. Applicable F&A (indirect) costs can also be requested.
  • The application budget is limited to one year only.
  • Supplements may provide support above the dollar limits of the funding opportunity announcement of the parent grant award.
  • Earliest start date – August 2025
Purpose

The Office of Research on Women’s Health (ORWH) announces the availability of administrative supplements to support research to address health disparities among women in the United States who are underrepresented, underserved, and underreported (U3) in biomedical research.

Key Definitions

  • NIH Populations with Health Disparities: Racial and ethnic minority groups, people with lower socioeconomic status, underserved rural populations, sexual and gender minority (SGM) groups, and people with disabilities.
  • NIH Populations with Health Disparities: Racial and ethnic minority groups, people with lower socioeconomic status, underserved rural populations, sexual and gender minority (SGM) groups, and people with disabilities.
  • Intersectionality: Intersectionality describes how individuals’ multiple, social identities (e.g., gender, racial group, class, sexual orientation, and disability status) intersect to shape position in society, overall lived experience, and health.
  • Social determinants of health: Conditions in the environments where people are born, live, learn, work, play, worship, and age that affect a wide range of health, functioning and quality-of-life outcomes and risks.
Topics of interest include, but are not limited to:
  • Studies evaluating interventions to reduce health disparities among women from U3 populations
  • Studies to improve our understanding of how social determinants of health and other factors (e.g., immigration status, English proficiency) influence health disparities experienced by women
  • Studies exploring the etiologies underlying health disparities in prevention, treatment or outcomes from female-specific or gynecologic conditions (e.g., menopause, menstrual mood disorders, PCOS, endometrial cancer)
  • Studies exploring the etiologies underlying health disparities in prevention, treatment or outcomes from diseases that disproportionately affect women (e.g., autoimmune disorders, mental health diseases)
  • Studies exploring etiologies underlying health disparities in prevention, treatment or outcomes from diseases that present and progress differently in women (e.g., cardiovascular disease, metabolic conditions, substance use disorders).
  • Studies seeking to identify novel dissemination, outreach, and implementation approaches by which research findings can reach populations of U3 women
  • Studies exploring the causes of differences in entry, utilization, and retention of primary and preventive health care services and treatment adherence among populations of U3 women
  • Studies exploring geographic and structural barriers to care-seeking behavior and outcomes of U3 women
  • Studies exploring caretaking/caregiving responsibilities, gender discrimination, and other structural barriers to healthcare utilization for U3 women
  • Studies to accelerate research on technologies to overcome barriers and increase uptake of preventative interventions and effective therapeutics at the point of care for women from underserved communities (e.g., Federally Qualified Health Center (FQHC), community hospitals, Indian Health Service affiliated hospitals/health facilities)
  • Studies exploring chronic conditions and/or multimorbidity in U3 women
  • Studies exploring social and structural determinants of health in maternal health and maternal morbidity and mortality for U3 women
  • Studies exploring the effects of direct and indirect exposures to violence and trauma across the lifespan, including intimate partner violence among U3 women

Please direct questions about this opportunity to Karen Hough at khough@udel.edu